Rankings
▼
Calendar
ALGS Q1 2024 Earnings — Aligos Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALGS
Aligos Therapeutics, Inc.
$45M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$986,000
-63.8% YoY
Gross Profit
$986,000
100.0% margin
Operating Income
-$22M
-2235.9% margin
Net Income
-$35M
-3535.8% margin
EPS (Diluted)
$-2.24
QoQ Revenue Growth
-63.2%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$128M
Total Liabilities
$68M
Stockholders' Equity
$60M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$986,000
$3M
-63.8%
Gross Profit
$986,000
$3M
-63.8%
Operating Income
-$22M
-$24M
+7.8%
Net Income
-$35M
-$23M
-51.9%
← FY 2024
All Quarters
Q2 2024 →